27th March 2020
Technology offered to increase speed of blood testing in the clinical setting during COVID-19 pandemic
Hemcheck offers a unique solution, HELGE™ which detects hemolysis in blood samples in vacuum tubes and blood gas syringes during blood sampling at the point of care.
HELGE™ contributes to more informed and timely clinical decisions. Given the critical situation with the outbreak and rapid spread of COVID-19 in society, HELGE™ could improve the flows of blood samples in clinical laboratories, emergency departments, infection clinics, intensive care units and ambulatory/mobile units. This in turn would decrease the turnaround time and overcrowding as well as reduce the workload of the healthcare staff.
The offer is valid for three months free of charge, the time period may be prolonged.
ASK: Research contributors needed for CON-VICE study
University of Luxembourg needs European researchers to get in touch
OFFER: Funding available for COVID-19 research
Fondation Air Liquide are looking to fund European projects
ASK: Supporting the immunocompromised
Partners sought to advance neutralising antibody